Encellin news and milestones
Encellin: 8 headlines on record, 3 headlines in the last 90 days. Its story counts 5 milestones.
Data updated Nov 17, 2026 · Back to the company report
8Headlines
3In 90 days
5Milestones
Headlines
Sep 222026
News · YahooFinance
Encellin Partners with Breakthrough T1D to Advance Immune-Protected Cell Therapy for Type 1 Diabetes
SAN FRANCISCO & NEW YORK & MONTREAL, September 22, 2026--Encellin, Inc., a clinical-stage biotechnology company developing Encapsulated Cell Replacement Therapy (ENCRT), today an…
Sep 222026
Jan 62026
News · YahooFinance
SAN FRANCISCO, January 06, 2026--Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ong…
Jan 62026
Press release · businesswire.com
On January 6th, 2026, Encellin reported positive interim results of its Phase 1 clinical trial of encapsulated islets in people with type 1 diabetes (T1D).
Dec 20, 20232023
News · Pulse 2.0
Encellin - a biotechnology company developing a cell encapsulation platform with an initial focus on Type 1 Diabetes (T1D) - recently announced the closing of a $9.9 million fina…
Dec 13, 20232023
Press release · businesswire
Encellin Closes $9.9M Financing Led by Khosla Ventures to Advance Cell Encapsulation Platform for Endocrine Disorders
Aug 5, 20212021
Press release · businesswire
Encellin Closes $5.9M Seed Financing co-led by Khosla Ventures and SV Latam Capital
Sources: the outlets named on each headline, each story once
Milestones
Sep 20, 2023
Jun 28, 2019
2015
Founded
Each milestone is dated by its source: registers, filings, the press
How to cite
Encellin, News. Alion, Nov 17, 2026. https://alion.io/company/encellin/news
